During the past decade, Sarah Cannon Blood & Marrow Transplant Program conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sarah Cannon Blood & Marrow Transplant Program" #1 collaborator was "Blood and Marrow Transplant Clinical Trials Network" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator and "National Marrow Donor Program" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Sarah Cannon Blood & Marrow Transplant Program" are "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Sarah Cannon Blood & Marrow Transplant Program" in a lesser frequency.

Most popular intervention types in "Sarah Cannon Blood & Marrow Transplant Program" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lenalidomide" (2 trials) and "lenalidomide, bortezomib and dexamethasone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sarah Cannon Blood & Marrow Transplant Program" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Sarah Cannon Blood & Marrow Transplant Program". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Sarah Cannon Blood & Marrow Transplant Program, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sarah Cannon Blood & Marrow Transplant Program, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".